Document is current
Any future updates will be listed below
-
Authors
Chalder, Lynda
Elremaly, Wesam
Li, Dawei
Fang, Yu
Caraus, Iurie
Leveau, Corinne
Elbakry, Mohamed
Franco, Anita
Godbout, Christian
Di Tomasso, Geneviève
Nepotchatykh, Evguenia
Rostami-Afshari, Bita
Gimenez, Michael
Legault, Pascale
Moreau, Alain https://orcid.org/0009-0002-1144-6174
-
Funding
Funding for this research was provided by:
Sibylla-Hesse Foundation (Sibylla-Hesse Foundation)
The Open Medicine Foundation Canada (The Open Medicine Foundation Canada)
Parkinson Canada (Parkinson Canada)
Laparé and Legault Funds in Biochemistry for Research in RNA Biology and Neurodegenerative Diseases (Laparé and Legault Funds in Biochemistry for Research in RNA Biology and Neurodegenerative Diseases)
CIHR (PJT 186036)
Bristol-Myers-Squibb Chair in Molecular Biology at the Université de Montréal (Bristol-Myers-Squibb Chair in Molecular Biology at the Université de Montréal)
- License Information
-
More Information
Article History
Received: 2 December 2025
Accepted: 12 April 2026
First Online: 20 April 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of CHU Sainte-Justine (protocol #4047). Informed consent was obtained from all participants involved in the study.
: Not applicable.
: AM is the Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network, a national research network funded by The Canadian Institutes of Health Research (grant MNC–196095 and MNC–196095 to A.M.) and a member of the Scientific Advisory Board of the Open Medicine Foundation (USA).
